Clinical Trial Update: Functional Change and Efficacy of Duloxetine in Patients With Co-Morbid Depression & Soft Tissue Discomfort Syndrome [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating functional change and efficacy of duloxetine in patients with co-morbid major depressive disorder and soft tissue discomfort syn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Pain
• Soft Tissue Discomfort Syndrome

Drugs mentioned

• Duloxetine (DULOXETINE)

Snippet

Sponsor: University of Pennsylvania | Conditions: Major Depressive Disorder, Soft Tissue Discomfort Syndrome | Phase 4 | Status: COMPLETED | Results posted: 2020-04-16